Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from EBOS Group Limited ( (AU:EBO) ).
EBOS Group Limited has applied for quotation on the ASX of 6,948 ordinary fully paid shares issued under its employee incentive scheme. The new securities, which are not subject to transfer restrictions, modestly increase the company’s quoted share capital and reflect the ongoing use of equity-based remuneration to align staff incentives with shareholder interests.
The most recent analyst rating on (AU:EBO) stock is a Buy with a A$30.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited is a healthcare and pharmaceutical products company listed on the ASX under the code EBO. It operates in the distribution and related services segment, supplying medicines and health products across Australia and New Zealand to pharmacies, hospitals, and other healthcare providers.
Average Trading Volume: 125,434
Technical Sentiment Signal: Sell
Current Market Cap: A$3.84B
See more data about EBO stock on TipRanks’ Stock Analysis page.